Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...
A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...
Sun, March 29, 2026 at 12:15 PM UTC SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
Sen. Bill Cassidy (R-La.) faces a tough situation as he questions Robert F. Kennedy Jr. in two Senate hearings.
A Republican senator juggling three roles — lawmaker, doctor and political candidate seeking reelection — walked a fine line ...
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head studyFirst head-to-head, double-blind, ...
"RNA modifications are central to how cells respond to their environment," said Gudrun Stengel, Ph.D., Chief Executive Officer of Alida Biosciences. "With EpiPlex Tri-Mod, we move beyond method ...
The AIRFoundry facility — funded by a six-year, $18 million National Science Foundation grant — brings together researchers ...
Bill Cassidy, who is seeking reelection, walked a fine line ...